NYSE · LDI

loanDepot, Inc.

$1.01 +$0.04 (+4.39%) 1D After hours

Key Metrics

$524.74M
Market cap
P/E · TTM
Revenue · TTM
−$78.24M
Net income
EPS · TTM $-0.14
Dividend yield 0.5%
Free cash flow −$725.12M
Beta · 1Y 2.28
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 23
    From its Jan 29 high, the share price fell 58%.

    Peak close $2.33 on Jan 29; trough close $0.97 on Jul 23. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -58%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 14
    The stock moved +9.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 14
  • Apr 17
    The stock moved +9.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 17

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$524.74M
Enterprise value$2.36B
Shares outstanding542.4M
52-wk range$0.93 – $5.05
Avg volume · 20D1.4M
Net cash −$1.84B
Book value / share$0.62
IndustryFinance Services
ExchangeNYSE
About loanDepot, Inc.
IPO dateFeb 11, 2021
Employees4695

loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC -18.5% · -5.6%

Financial Health

Current ratio
Quick ratio
Debt / equity6.27
Debt / EBITDA
Net cash −$1.84B
Working capital

Cash Flow · TTM

Operating CF −$696.97M
Capex −$28.15M
Free cash flow −$725.12M
Buybacks
Dividends paid $2.47M
Shareholder yield 0.5%

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings